This article explores nutritional and medical strategies to support lung cancer management. It highlights foods like blueberries and salmon, herbal remedies such as rosemary and basil, and medical treatments including immunotherapy options like TECENTRIQ® and ZEPZELCA®. The advice emphasizes the importance of professional healthcare consultation and provides useful insights for patients seeking supportive care options alongside conventional treatments.

Nutritional Strategies and Therapies to Aid Lung Cancer Patients

Lung cancer develops from abnormal cell growth in the lung's airways. The main types are small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC). Less common forms include carcinoid tumors, which grow slowly as neuroendocrine tumors. Although a definitive cure is not yet available, specific foods, herbs, and medical treatments can help manage symptoms and bolster treatment efforts.

Dietary Choices Supporting Symptom Relief

Certain foods may provide benefits to lung cancer patients.

Blueberries
Rich in quercetin, a strong antioxidant, blueberries may help inhibit cancer cell growth and slow disease progression.

Salmon
Contains high levels of vitamin D, salmon supports lung health and may prevent cancer cell proliferation. Other beneficial fats include mackerel and herring.

Herbal Support
Certain herbs are recognized for their supportive effects in lung cancer treatment.

Rosemary
Known for its potential to reduce cancerous cells, rosemary includes polyphenols like carnosic acid and rosmarinic acid, which help suppress tumor growth and boost immune defenses.

Basil
Used traditionally in cooking and medicine, basil offers antioxidants such as beta-carotene, zeaxanthin, lutein, and beta-cryptoxanthin that may protect against cancer cell damage.

Medical Therapies
In addition to nutrition and herbal remedies, various medical options support lung cancer management.

TECENTRIQ® (atezolizumab)
An immunotherapy approved for non-small cell lung cancer (NSCLC), which helps decrease recurrence risk post-surgery and is combined with chemotherapy for Stage 2 to 3A NSCLC.

ZEPZELCA® (lurbinectedin)
Approved for adult patients with small cell lung cancer (SCLC), especially in cases of metastasis or chemotherapy resistance, ZEPZELCA® provides an alternative treatment approach.

Note:

The information here on symptoms, treatments, and health conditions aims to inform but should not replace professional medical advice. Always seek guidance from qualified healthcare providers for diagnosis and treatment plans. Use this information responsibly and consult experts as needed.